| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 443797-96-4 | JNJ-7706621 |
≥98% | | 询价 |
| 2 | 1000669-72-6 | KW-2449 |
≥98% | | 询价 |
| 3 | 885325-71-3 | MK-8745 |
≥98% | | 询价 |
| 4 | 1207293-36-4 | BI-847325 |
≥98% | | 询价 |
| 5 | 827318-97-8 | Danusertib(PHA739358) |
≥98% | | 询价 |
| 6 | 477600-75-2 | Tofacitinib |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 7 | 869363-13-3 | MLN8054 |
≥98% | | 询价 |
| 8 | 331771-20-1 | ZM 447439 |
≥98% | | 询价 |
| 9 | 722544-51-6 | Barasertib(INH-34 AZD-1152-HQPA) |
≥98% | | 询价 |
| 10 | 639089-54-6 | Tozasertib(VX680 MK0457) |
≥98% | | 询价 |
| 11 | 1028486-01-2 | Alisertib(MLN8237,MLN-8237) |
≥98% | | 询价 |
| 12 | 477600-75-2 | Tofacitinib(CP690550 tasocitinib) |
≥98% | | 询价 |
| 13 | 1229236-86-5 | Gandotinib(LY-2784544) |
≥98% | | 询价 |
| 14 | 1187594-09-7 | Baricitinib(LY-3009104,INCB-028050) |
≥98% | | 询价 |
| 15 | 1146618-41-8 | SNS-314 Mesylate |
≥98% | | 询价 |
| 16 | 1257704-57-6 | CEP-33779 |
≥98% | | 询价 |
| 17 | 4871-97-0 | Curcumol |
≥98% | | 询价 |
| 18 | 937272-79-2 | Pacritinib(SB1518) |
≥98% | | 询价 |
| 19 | 945755-56-6 | XL019 |
≥98% | | 询价 |
| 20 | 1021868-92-7 | ZM 39923 HCl |
≥98% | | 询价 |
| 21 | 1206101-20-3 | GLPG0634 analogue |
≥98% | | 询价 |
| 22 | 136194-77-9 | Go6976(PD40697) |
≥98% | | 询价 |
| 23 | 5108-96-3 | Pyrrolidinedithiocarbamate ammonium(PDTC) |
| 50mg, 100mg, 200mg | 询价 |
| 24 | 1206161-97-8 | Filgotinib(GLPG-0634) |
≥98% | | 询价 |
| 25 | 1369761-01-2 | Cerdulatinib HCl salt |
≥98% | | 询价 |
| 26 | 1226895-15-3 | FLLL32 |
≥98% | | 询价 |
| 27 | 1056634-68-4 | Momelotinib(LM1149 CYT387 CYT11387) |
≥98% | | 询价 |
| 28 | 133550-30-8 | AG-490(Tyrphostin B42 zinc0255794) |
≥98% | | 询价 |
| 29 | 944118-01-8 | Peficitinib(ASP-015K,JNJ-54781532) |
≥98% | | 询价 |
| 30 | 944842-54-0 | Decernotinib(VX-509 VRT-831509 adelatinib) |
≥98% | | 询价 |
| 31 | 1271022-90-2 | BMS-911543 |
≥98% | | 询价 |
| 32 | 896466-04-9 | AT9283 |
≥98% | | 询价 |
| 33 | 936091-26-8 | Fedratinib(SAR302503) |
≥98% | | 询价 |
| 34 | 935666-88-9 | AZD1480 |
≥98% | | 询价 |
| 35 | 540737-29-9 | Tofacitinib(CP690550)Citrate |
≥98% | | 询价 |
| 36 | 941678-49-5 | Ruxolitinib(INCB-018424 INC-424) |
≥98% | | 询价 |
| 37 | 927822-86-4 | KC7F2 |
≥98% | | 询价 |
| 38 | 223387-75-5 | FG-2216 |
≥98% | | 询价 |
| 39 | 685898-44-6 | PX-478 2HCl |
≥98% | | 询价 |
| 40 | 1227158-85-1 | BAY 87-2243 |
≥98% | | 询价 |
| 41 | 931398-72-0 | IOX2 |
≥98% | | 询价 |
| 42 | 1797989-42-4 | CHIR-99021(CT99021)HCl |
≥98% | | 询价 |
| 43 | 552325-73-2 | A-674563 |
≥98% | | 询价 |
| 44 | 885499-61-6 | CCT128930 |
≥98% | | 询价 |
| 45 | 35943-35-2 | Triciribine |
≥98% | | 询价 |
| 46 | 391210-10-9 | Mirdametinib(PD0325901) |
| 5mg, 10mg, 50mg, 100mg | 询价 |
| 47 | 857531-00-1 | AT7867 |
≥98% | | 询价 |
| 48 | 28718-90-3 | DAPI Dihydrochloride |
| 5mg, 10mg, 25mg, 50mg | 询价 |
| 49 | 1001264-89-6 | Ipatasertib(GDC0068 RG7440) |
≥98% | | 询价 |
| 50 | 937174-76-0 | GSK-690693 |
≥98% | | 询价 |
| 51 | 157716-52-4 | Perifosine(KRX0401) |
≥98% | | 询价 |
| 52 | 1032350-13-2 | MK-2206 2HCl |
≥98% | | 询价 |
| 53 | 1608125-21-8 | AMG319(ACP-319) |
≥98% | | 询价 |
| 54 | 1627494-13-6 | AZD8186 |
≥98% | | 询价 |
| 55 | 1276553-09-3 | PF-4989216 |
≥98% | | 询价 |
| 56 | 934526-89-3 | Pilaralisib(XL147) |
≥98% | | 询价 |
| 57 | 955977-50-1 | PI-3065 |
≥98% | | 询价 |
| 58 | 1276110-06-5 | HS-173 |
≥98% | | 询价 |
| 59 | 117-39-5 | Quercetin(Sophoretin NSC 9221 Kvercetin) |
≥98% | | 询价 |
| 60 | 1394076-92-6 | GNE-317 |
≥98% | | 询价 |
m.cnreagent.com